Which One Would be supreme gem? – Teck Resources Limited (TECK), Atara Biotherapeutics, Inc. (ATRA)

The shares of Teck Resources Limited have decreased by more than -18.99% this year alone. The shares recently went up by 3.38% or $0.57 and now trades at $17.45. The shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA), has slumped by -59.38% year to date as of 08/13/2019. The shares currently trade at $14.11 and have been able to report a change of 13.24% over the past one week.

The stock of Teck Resources Limited and Atara Biotherapeutics, Inc. were two of the most active stocks on Tuesday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. These figures suggest that TECK ventures generate a higher ROI than that of ATRA.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for TECK is 2.50 and that of ATRA is 10.00. This implies that it is easier for TECK to cover its immediate obligations over the next 12 months than ATRA. The debt ratio of TECK is 0.25 compared to 0.00 for ATRA. TECK can be able to settle its long-term debts and thus is a lower financial risk than ATRA.


TECK currently trades at a forward P/E of 6.72, a P/B of 0.56, and a P/S of 1.09 while ATRA trades at a P/B of 2.29, This means that looking at the earnings, book values and sales basis, TECK is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of TECK is currently at a -45.67% to its one-year price target of 32.12. Looking at its rival pricing, ATRA is at a -66.06% relative to its price target of 41.57.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), TECK is given a 2.20 while 1.80 placed for ATRA. This means that analysts are more bullish on the outlook for TECK stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for TECK is 3.78 while that of ATRA is just 11.30. This means that analysts are more bullish on the forecast for TECK stock.


The stock of Teck Resources Limited defeats that of Atara Biotherapeutics, Inc. when the two are compared, with TECK taking 5 out of the total factors that were been considered. TECK happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, TECK is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for TECK is better on when it is viewed on short interest.